We are live on ! Find out more

10 hedge funds and large institutions have $4.85M invested in BioVie in 2021 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

5% more capital invested

Capital invested by funds: $4.62M → $4.85M (+$233K)

0% more funds holding

Funds holding: 1010 (0)

0% less ownership

Funds ownership: 0.02%0.01% (-0%)

0% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 5

Holders
10
Holders Change
Holders Change %
0%
% of All Funds
0.17%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
4
Reduced
1
Closed
5
Calls
Puts
Net Calls
Net Calls Change

BIVI Hedge Fund Activity: Q2 2021 in Review

10 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in BioVie (BIVI) for Q2 2021, worth a combined $4.85M — up 5% from $4.62M a quarter earlier.

Fund positioning in BIVI was balanced in Q2 2021: 5 funds opened new positions, 5 closed out, 4 added to existing stakes and 1 trimmed.

The largest buyer was Vanguard Group, adding an estimated $1.11M. The largest seller was Millennium Management, exiting entirely with an estimated $447K sold.

  • 10 institutional investors held BioVie (BIVI) as of Q2 2021, unchanged from Q1 2021.
  • Funds reported $4.85M of BioVie stock for Q2 2021, up 5% quarter-over-quarter.
  • 5 funds opened new BioVie positions in Q2 2021 and 5 closed out, a net change of 0 holders.
  • The largest BioVie buyer in Q2 2021 was Vanguard Group, an estimated $1.11M added.
  • The largest BioVie seller in Q2 2021 was Millennium Management, an estimated $447K sold.

Based on aggregated 13F filings for Q2 2021.